Shrink polymer based electrochemical sensor for point-of-care detection of prostate-specific antigen
Biosensors and Bioelectronics · 2023-05 · 228 · 115193
DOI: 10.1016/j.bios.2023.115193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023-05. Verfasst von Wenzheng He und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Precision Measurement Technology and Instruments, Department of Precision Instruments, Tsinghua University, Beijing, 100084, …. Hauptthemen laut MEDLINE: Biosensing Techniques, Metal Nanoparticles. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
There is a growing but unmet need for point-of-care detection of prostate-specific antigen (PSA) in body fluid which may facilitate early diagnosis and therapy of prostate cancer in a cost-effective and user-friendly way. Low sensitivity and narrow detection range limits applications of point-of-care testing in practice. Here, an immunosensor is first presented based on shrink polymer and integrated into a miniaturized electrochemical platform for detecting PSA in clinical samples. The sensing electrode was prepared by sputtering a gold film on shrink polymer, followed by heating to shrink the electrode to a small size with wrinkles from nano-scale to micro-scale. These wrinkles can be directly regulated by the thickness of the gold film with high specific areas for enhancement of antigen-antibody binding (3.9 times). A distinct difference between electrochemical active surface area (EASA) and response to PSA of shrink electrodes was observed and discussed. The electrode was treated with air plasma and modified with self-assembled graphene to further enhance the sensor's sensitivity (10.4 times). The shrink sensor with gold 200 nm thick integrated into the portable system was validated by a label-free immunoassay for detection of PSA in 20 μL serum within 35 mins. It exhibited a limit of detection of 0.38 fg/mL, the lowest among label-free PSA sensors, and a wide linear response from 10 fg/mL to 1000 ng/mL. Moreover, the sensor demonstrated reliable assay results in clinical serums, comparable to the commercial chemiluminescence instrument, confirming its feasibility for clinical diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Precision Measurement Technology and Instruments, Department of Precision Instruments, Tsinghua University, Beijing, 100084, China.
- Department of Urology, Jilin Cancer Hospital, Jilin Province, Changchun, 130012, China.
- Department of Urology, Jilin Cancer Hospital, Jilin Province, Changchun, 130012, China. Electronic address: zcdjt2199@163.com.
- State Key Laboratory of Precision Measurement Technology and Instruments, Department of Precision Instruments, Tsinghua University, Beijing, 100084, China. Electronic address: xyye@mail.tsinghua.edu.cn.
- Department of Mechanical Engineering, University of Minnesota, 111 Church Street S.E., Minneapolis, MN, 55455, USA. Electronic address: cuixx006@umn.edu.
Zitieren
APA
He, W., Liu, L., Cao, Z., Lin, Y., Tian, Y., Zhang, Q., Zhou, C., Ye, X., & Cui, T. (2023). Shrink polymer based electrochemical sensor for point-of-care detection of prostate-specific antigen. Biosensors and Bioelectronics, 228, 115193. https://doi.org/10.1016/j.bios.2023.115193
Vancouver
He W, Liu L, Cao Z, Lin Y, Tian Y, Zhang Q, et al. Shrink polymer based electrochemical sensor for point-of-care detection of prostate-specific antigen. Biosensors and Bioelectronics. 2023;228:115193. doi:10.1016/j.bios.2023.115193
BibTeX
@article{He2023,
author = {He, Wenzheng and Liu, Liying and Cao, Zeyuan and Lin, Yang and Tian, Yuxin and Zhang, Qifu and Zhou, Changdong and Ye, Xiongying and Cui, Tianhong},
title = {Shrink polymer based electrochemical sensor for point-of-care detection of prostate-specific antigen},
journal = {Biosensors and Bioelectronics},
year = {2023},
volume = {228},
pages = {115193},
doi = {10.1016/j.bios.2023.115193}
}
EUVIMED